title: Should patients with high-risk prostate cancer receive 6 months or 3 years of adjuvant androgen suppression therapy?
authors: Department of Urology, University of Michigan, Ann Arbor, MI 48104-0330, USA. sethstro@med.umich.edu
authors: Seth
authors: S
authors: Strope
authors: David P
authors: DP
authors: Wood